Comprehensive Tumor Profiling
Gain insights with detailed genetic analysis for personalized cancer treatment strategies.
Whole-exome & RNA-seq Synergy
Captures driver mutations, gene fusions, copy-number changes, MSI, and TMB in a single run.
Actionability Tiering
Each variant is automatically linked to FDA/EMA-approved drugs, NCCN guidelines, and active clinical trials.
Rapid Processing
Turnaround in 5-7 days - stat 72-hour option for rapidly progressing cases.
EMR-Ready Delivery
Interactive PDF plus FHIR bundle for seamless import.
Predictive Treatment Outcomes
Access data-driven predictions to evaluate potential responses to oncology treatments.
Machine-Learned Response Curves
Trained on >200k de-identified cases for reliable predictions.
Therapy Comparison Widget
Model how chemo, targeted agents, or immunotherapy may shift PFS and OS for your patient.
Confidence Intervals at a Glance
Transparent ranges, never black-box "scores" alone.
Built-in Trial Eligibility Flags
When real-world evidence suggests limited benefit.
Advanced Biomarker Identification
Identify key biomarkers that guide targeted-therapy decisions, enhancing treatment precision.
Multi-omic Mining
Integrates DNA, RNA, protein, and methylation signals to uncover novel drivers.
Pathway Heat-maps
Spotlight dominant oncogenic circuits for combination-therapy planning.
Real-time Literature Sync
Each biomarker entry enriched with the latest PubMed and ASCO abstracts.
Custom Alerting
Get notified when new drug-biomarker pairs enter Phase II/III.
Genomic Data Integration
Seamlessly integrate multi-source genomic data for a holistic view of the patient's cancer profile.
One-click Ingest
Of local NGS results, liquid-biopsy reports, and public datasets (TCGA, AACR GENIE).
Harmonized Across Pipelines
Liftover, deduplication, and HGVS normalization done automatically.
Patient Timeline Lens
Merges genomic events with imaging, labs, and outcomes for longitudinal tracking.
Secure, Standards-based APIs
Enable bidirectional flow with hospital EMRs and research LIMS.